Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found ...
But taken together, the requests formed a pattern — one that, in retrospect, traced a regulatory trail that would later reveal unexpectedly high pacemaker battery failure rates, jeopardizing the lives ...
ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
For years, Boston Scientific's factory tests revealed pacemaker batteries that were failing unexpectedly, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results